However, resolution of NASH did not reach statistical significance (36 % vs. 21 %, p = 0.05), an endpoint only reached in the same study by pioglitazone (47 %, p = 0.001 vs. placebo).
← all excerpts
Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus.
1
0.0500
0.0500